Placeholder canvas

US FDA Approves Emergency Use Of Pfizer-BioNTech Vaccine For Children In 12-15 Age Group

Date:

The US Food and Drug Administration (FDA) on Monday authorised the emergency use of the Pfizer-BioNTech COVID-19 vaccine to children in the age group of 12-15 years.

Amending the Emergency Use Approval (EUA) issued on December 11, 2020, for administration in individuals above the age of 16, FDA Commissioner Janet Woodcock said: “The FDA’s expansion of the emergency use authorisation for the Pfizer-BioNTech COVID-19 vaccine to include adolescents 12 through 15 years of age is a significant step in the fight against the COVID-19 pandemic.” “Today’s action allows for a younger population to be protected from COVID-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic. Parents and guardians can rest assured that the agency undertook a rigorous and thorough review of all available data, as we have with all of our COVID-19 vaccine emergency use authorisations,” she added.

The FDA has determined that Pfizer-BioNTech COVID-19 vaccine has met the statutory criteria to amend the EUA, and that the known and potential benefits of this vaccine in individuals 12 years of age and older outweigh the known and potential risks, supporting the vaccine’s use in this population, the body said in a statement.

Also Read : Chinese Scientists Discussed Weaponising Coronavirus In 2015: Report

It noted that children and adolescents generally have a milder COVID-19 disease course as compared to adults.

Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said: “Having a vaccine authorised for a younger population is a critical step in continuing to lessen the immense public health burden caused by the COVID-19 pandemic.”

“With science guiding our evaluation and decision-making process, the FDA can assure the public and medical community that the available data meet our rigorous standards to support the emergency use of this vaccine in the adolescent population 12 years of age and older,” he further said.

The most commonly reported side effects in the adolescent clinical trial participants, which typically lasted 1-3 days, were pain at the injection site, tiredness, headache, chills, muscle pain, fever and joint pain, according to the statement.

However, it was warned that the Pfizer-BioNTech COVID-19 vaccine should not be given to anyone with a known history of a severe allergic reaction, including anaphylaxis. “The immune response to the vaccine in 190 participants, 12 through 15 years of age, was compared to the immune response of 170 participants, 16 through 25 years of age. In this analysis, the immune response of adolescents was non-inferior to (at least as good as) the immune response of the older participants,” the FDA noted.

Since December last year, companies have delivered more than 170 million doses of the vaccine across the US. The Pfizer-BioNTech vaccine was also determined to be more than 91 percent effective in preventing symptomatic COVID-19 at least six months after the second dose.

Click here for Latest News updates and viral videos on our AI-powered smart news

For viral videos and Latest trends subscribe to NewsMobile YouTube Channel and Follow us on Instagram

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

Popular

More like this
Related

Biden Administration Approves $60Million Aid For Baltimore Bridge Collapse

The Federal Administration in a statement on Thursday said that it has provided the quick-release funds to rebuild the collapsed bridge within hours of receiving a request from Maryland Department Of Transportation

Fact Check: Lok Sabha Polls Will Be Held Using EVMs; Don’t Fall For False Claim

Ahead of the Lok Sabha polls, a newspaper cutout...

Four Killed, Five Wounded In Stabbing Incident In North Illinois

Redd mentioned that not all of the victims had stab wounds and none of them were shot. She added by saying that they have a suspect in custody

Hope Everyone’s Rights Are Protected: UN On Kejriwal’s Arrest

Delhi CM Kejriwal was arrested by the ED(Enforcement Directorate) on March 21 in the Delhi liquor policy case, days ahead of the Lok Sabha polls